cerrar
Tagged with Strategy

Mirela Iordan – Country Manager, Pfizer Romania
Mirela Iordan country manager of Pfizer Romania reveals some of her milestones, including integrating new acquisitions and setting up the first…

Louis Cheng – CEO, Leadgene Biomedical, Taiwan
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody technologies, his ambitious…

Omar Lugo Aguirre – Country Lead, nPVU & Market…
UCB’s Omar Lugo Aguirre outlines the company’s response to the COVID-19 pandemic in Mexico, countering stigmas around neurodegenerative and mental…

Chinese Biotechs’ Domestic Pricing Strategies
Alphamab Oncology and I-Mab Biopharma, two of China’s fastest-growing biotech firms, both bolstered by recent successful IPOs, are increasingly…

Tarek El Rahbani – Managing Director MENA, Boston…
Working non-stop to catch up with its footprint in other regions, Boston Scientific is investing heavily in the MENA markets. Tarek El Rahbani,…

Sonja Willems – Managing Director, Janssen Benelux
Janssen in Belgium was founded in 1953 by Dr Paul Janssen, with only one thing in mind: saving people’s lives through the development of better…

Karim Lahlou – General Manager, Iberma, Morocco
Karim Lahlou of Moroccan pharma manufacturer Iberma discusses the firm's evolution in recent years, the abundant opportunities for Iberma in the…

Aldo Donati – CEO, IBSA USA
Aldo Donati, CEO for Swiss firm IBSA in the USA, discusses the challenges for European mid-caps in expanding to the US market and his portfolio…

Mohamed El Bouhmadi – President & CEO, Zenith Pharma,…
Mohamed El Bouhmadi, president and CEO of Zenith Pharma, walks us through the company’s evolution since we last met in 2015. He shares his strategy…

Karel Van De Sompel – Country Manager, Pfizer Belgium…
Karel Van De Sompel, country manager of Pfizer in Belgium and Luxembourg and chairman of Pharma.be, highlights the key changes he sees in today’s…

Jielun Zhu – CFO, I-Mab Biopharma, China
I-Mab Biopharma CFO Jielun Zhu recaps the exciting milestones for the company over the past year since our last interview in May 2019, including most…

Management in the Age of Confinement
With the global coronavirus pandemic still ongoing and teleworking having become the new normal, pharma executives from across the world are giving us…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here